Contoura With Phorcides Compared to Wavefront Optimized LASIK

Last updated: April 24, 2023
Sponsor: Daniel Terveen
Overall Status: Active - Recruiting

Phase

N/A

Condition

Astigmatism

Myopia

Treatment

N/A

Clinical Study ID

NCT05486546
AMPLIO
  • Ages 21-38
  • All Genders

Study Summary

Comparing post-operative visual acuity and patient reported satisfaction between Contoura with Phorcides and WaveLight Wavefront Optimized.

Eligibility Criteria

Inclusion

Inclusion Criteria:

  • Patients at least age 21 years of age undergoing LASIK eye surgery
  • Willing and able to comprehend informed consent and complete 1 month post-op visit
  • Potential postoperative BCDVA of 20/20 or better in each eye based on Investigator'smedical opinion
  • Candidates for Contoura with Phorcides (Myopic, astigmatism <3.0D)
  • Both eyes targeted for plano
  • Pre-operative total corneal Pachymetry 490um or above
  • Stable refractive error <0.50D change in preceding year
  • Good general and ocular health
  • Pre-operative exam completed within three months of surgery
  • SCL discontinued 3 days prior to pre-op exam and the procedure
  • Pachymetry above 490 with residual greater than 270um
  • Candidates who, as determined by the investigator, can safely undergo LASIK

Exclusion

Exclusion Criteria:

  • Patients under 21 years of age
  • Concomitant ocular condition which would limit the BCVA at the discretion of thesurgeon
  • Patients with usual relative and absolute contraindications for LASIK surgery (Patients with severe dry eye, recurrent corneal erosion, uncontrolled Glaucoma,collagen vascular disorders, keratoconus or signs of keratoconus, uncontrolledDiabetes, Herpes)
  • Pachymetry below 490
  • Autoimmune or immunodeficiency diseases
  • Pregnant or nursing women
  • Patients with signs of inability to understand consent for study and procedure planned
  • Patients with history of previous ocular surgery
  • Patients with strabismus or amblyopia
  • Patients that have a BCDVA of 20/25 or worse in either eye

Study Design

Total Participants: 120
Study Start date:
August 15, 2022
Estimated Completion Date:
December 01, 2023

Connect with a study center

  • Vance Thompson Vison

    Bozeman, Montana 57105
    United States

    Active - Recruiting

  • Vance Thompson Vision

    Omaha, Nebraska 57105
    United States

    Active - Recruiting

  • Vance Thompson Vision

    Fargo, North Dakota 57105
    United States

    Active - Recruiting

  • Vance Thompson Vision

    Sioux Falls, South Dakota 57108
    United States

    Active - Recruiting

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.